Literature DB >> 32107907

MicroRNA-142-3p suppresses cell proliferation and migration in bladder cancer via Rac1.

W Q Li1, W C Zhao2, J Xin2, T L Niu2, Y F Chao2, P Zhou2, M H Zheng2, B Xu1.   

Abstract

Expression of microRNA(miR)-142-3p has been implicated to be associated with several cancers, whereas its function in bladder cancer (BC) remains unknown. The present study aimed to explore the correlation between the expression of miR-142-3p and the proliferation, migration and invasion of bladder cancer cells by activating Rac1. qRT-PCR was used to measure the expression of miR-142- 3p in bladder cancer tissues and cell lines. RNA transfection was used to silence and accelerate the expression of miR-142-3p in bladder cancer cells. CCK-8 and trans-well assays were used to detect the proliferation, migration and invasion of cells before and after RNA transfection. The direct interaction between Rac1 and miR-142-3p was demonstrated by a dual luciferase reporter assay. qRT-PCR and Western blot assays were used to detect the expression changes in Rac1 before and after transfection. The results showed that miR-142-3p in bladder cancer tissues was significantly lower than that in adjacent tissues and lower than that in HT1376 and T-24 cells but higher than that in T5637 and BIU- 87 cells. Additionally, upregulating miR-142-3p expression not only inhibits the proliferation of SV-HUC-1 and BIU-87 cells but also inhibits migration and invasion, and downregulating miR-142-3p expression showed the opposite results. The expression of Rac1 was promoted after stimulating miR- 142-3p expression, but was inhibited after silencing miR-142-3p expression. In conclusion, miR-142-3p affects the proliferation, migration and invasion of bladder cancer cells by regulating Rac1. Copyright 2020 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  Rac1; bladder cancer; invasion; microRNA-142-3p; migration; proliferation

Year:  2020        PMID: 32107907     DOI: 10.23812/19-460-A

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  7 in total

Review 1.  Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder.

Authors:  Vincent Sauzeau; Julien Beignet; Christian Bailly
Journal:  Biomedicines       Date:  2022-06-08

2.  MicroRNA‑142‑3p suppresses cell proliferation, invasion and epithelial‑to‑mesenchymal transition via RAC1‑ERK1/2 signaling in colorectal cancer.

Authors:  Na Xie; Qiuping Meng; Yixin Zhang; Zhifei Luo; Fenggui Xue; Sisi Liu; Ying Li; Yousheng Huang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

3.  Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.

Authors:  Feng Qiu; Qiuchen Liu; Yanfu Xia; Hengxi Jin; Yuxin Lin; Xiaojun Zhao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-14

4.  miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer.

Authors:  Guangyu Gao; Xiaofei Guo; Wenyong Gu; Yufeng Lu; Zhigang Chen
Journal:  Aging (Albany NY)       Date:  2022-04-22       Impact factor: 5.682

5.  Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p.

Authors:  Meropi Plousiou; Alessandro De Vita; Giacomo Miserocchi; Erika Bandini; Ivan Vannini; Mattia Melloni; Nestory Masalu; Francesco Fabbri; Patrizia Serra
Journal:  Cancer Manag Res       Date:  2022-06-29       Impact factor: 3.602

Review 6.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

7.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.